Acutaas Chemicals (NSE:ACUTAAS) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ACUTAAS Acutaas Chemicals Ltd NSE:ACUTAAS
73 GF Score
Price ₹3,213.70
GF Value ₹1,789.42
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Acutaas Chemicals Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

NSE:ACUTAAS
73GF Score
Acutaas Chemicals Ltd NSE:ACUTAAS
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Acutaas Chemicals (NSE:ACUTAAS) Overvalued in 2026?

Based on GuruFocus' analysis, Acutaas Chemicals stock appears to be overvalued. The current stock price of ₹3,213.70 is trading 79.6% above its estimated GF Value™ of ₹1,789.42. GuruFocus considers Acutaas Chemicals to be Significantly Overvalued.

Key valuation signals for NSE:ACUTAAS:

  • Interest Expense (Positive):
  • GF Value™: ₹1,789.42 vs. price of ₹3,213.70 (79.6% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the NSE:ACUTAAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acutaas Chemicals Business Description

Other Exchanges 543349:India
Address Road No. 82/A, Plot No. 440/4, 5 & 6, GIDC Sachin, District Surat, Surat, GJ, IND, 394230
Acutaas Chemicals Ltd is an Indian manufacturer of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), specialty chemicals, and formulations. Its product portfolio serves a range of industrial end-markets, including pharmaceuticals, personal care and cosmetics, battery chemicals, semiconductors, dyes, polymers, and agrochemicals. The company supplies customers both within India and internationally, and generates the majority of its revenue from exports, making it a significant participant in India's specialty chemicals and pharmaceutical intermediates export sector. Its business model centers on the manufacture and sale of chemical intermediates and specialty compounds to industrial customers, including pharmaceutical companies and other chemical processors, rather than finished consumer products. Revenue is derived primarily from product sales, with export markets accounting for the larger share of total turnover.
73GF Score

Get the complete analysis for NSE:ACUTAAS

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,213.70
Price
₹1,789.42
GF Value